Our GP is ready to help you if you want to be sure that you are healthy and in good shape, you have medical questions or problems and want to discuss with an experienced doctor, you have some unknown symptoms and want to know what they could be related to, you want to know another medical opinion about the best way of treatment of your disease.
Antibodies normally bind to foreign substances, such as bacteria and
viruses, and destroy them.
Antibody screening tests are done to detect antibodies against red blood
cells. Some conditions can result in the production of antibodies against red
blood cells.
Human blood is typed by the presence
of certain markers (antigens) on the surface of
red blood cells. Blood received in a transfusion must contain antigens
that are the same as the antigens on the recipient's own red blood cells (compatible
blood). If a person receives a transfusion of blood containing different antigens
(incompatible blood), the person's
immune system destroys the transfused blood cells. This destruction
is called a transfusion reaction and can cause serious illness or even death.
If the Rh-positive
blood of a fetus mixes with the blood of an Rh-negative
woman during pregnancy or delivery, the woman's immune system produces antibodies
against her fetus's red blood cells. This antibody response is called Rh sensitization.
Depending on when it occurs, it can destroy the fetus's red blood cells. Once sensitization has occurred,
the fetus can develop mild to severe problems (called Rh disease, hemolytic
disease of the newborn, or erythroblastosis fetalis). If untreated, complications
from sensitization can, in rare cases, lead to the death of an Rh-positive
fetus.
A form of hemolytic anemia called autoimmune hemolytic anemia
is a rare disease that causes a person to produce antibodies against his or
her own red blood cells.
The following two tests detect the presence of
antibodies against red blood cells: the indirect Coombs' test and the direct
Coombs' test. The indirect Coombs' test detects antibodies that could bind
to certain red blood cells, bringing problems if there is blood mixing. The
direct Coombs' test detects antibodies that are already attached to red blood
cells.
Both tests are done on a blood sample taken from a vein.
Antibody Screening Tests Results
Normal
Normal values for both tests are
negative (it means that no antibodies were detected).
Direct Coombs' test. A negative reaction means that your blood
contains no antibodies that are already attached to your red blood cells.
Indirect Coombs' test. A negative reaction means that your
blood is compatible with the blood you are to receive by transfusion. A negative
indirect Coombs' test for Rh factor (Rh antibody titer) in a pregnant woman
means that she has not developed antibodies against the blood of her fetus (if
her fetus has Rh-positive blood). This means that Rh sensitization
has not occurred.
Greater than normal values may mean
Direct Coombs' test. The detection of antibodies attached to
your red blood cells (a positive reaction) indicates that your blood has antibodies
against red blood cells in your bloodstream. This can be due to a transfusion
of incompatible blood or to conditions such as hemolytic anemia, systemic lupus erythematosus (SLE),
hemolytic disease of the newborn (HDN), or tumors of the lymph
nodes (lymphomas).
Indirect Coombs' test. The detection of
antibodies against red
blood cells from a donor (a positive reaction) may indicate that your blood
is incompatible with the donor's blood and you cannot receive blood from that
person. If the Rh antibody titer test is positive in a woman who is pregnant
or is planning to become pregnant, it means that her immune system has formed
antibodies against Rh-positive blood Rh sensitization. She will be tested to determine
the blood type of her fetus. If the fetus has Rh-positive blood, close monitoring
throughout the pregnancy is needed to prevent serious damage to the fetus's
red blood cells caused by the mother's immune system. If sensitization has
not occurred, it can usually be prevented by an injection of the
Rh immune globulin vaccine.